Kathryn Phillippi1, Mark Hoeltzel2, Angela Byun Robinson3, Susan Kim4. 1. Division of Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH. Electronic address: Kathryn.phillippi@uhhospitals.org. 2. Division of Pediatric Rheumatology, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI. 3. Division of Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children's Hospital/Case Medical Center, Cleveland, OH. 4. Division of Rheumatology, University of California at San Francisco, Benioff Children's Hospital, San Francisco, CA.
Abstract
OBJECTIVE: To determine the relationships among race, income, and disease outcomes in children with juvenile dermatomyositis (JDM). STUDY DESIGN: Data from 438 subjects with JDM enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry were analyzed. Demographic data included age, sex, race, annual family income, and insurance status. Clinical outcomes included muscle strength, presence of rash, calcinosis, weakness, physical function, and quality of life measures. Disease outcomes were compared based on race and income. RESULTS: Minority subjects were significantly more likely to have low annual family income and significantly worse scores on measures of physical function, disease activity, and quality of life measures. Subjects with lower annual family income had worse scores on measures of physical function, disease activity, and quality of life scores, as well as weakness. Black subjects were more likely to have calcinosis. Despite these differences in outcome measures, there were no significant differences among the racial groups in time to diagnosis or duration of disease. Using calcinosis as a marker of disease morbidity, black race, annual family income <$50 000 per year, negative antinuclear antibody, and delay in diagnosis >12 months were associated with calcinosis. CONCLUSION: Minority race and lower family income are associated with worse morbidity and outcomes in subjects with JDM. Calcinosis was more common in black subjects. Further studies are needed to examine these associations in more detail, to support efforts to address health disparities in subjects with JDM and improve disease outcomes.
OBJECTIVE: To determine the relationships among race, income, and disease outcomes in children with juvenile dermatomyositis (JDM). STUDY DESIGN: Data from 438 subjects with JDM enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry were analyzed. Demographic data included age, sex, race, annual family income, and insurance status. Clinical outcomes included muscle strength, presence of rash, calcinosis, weakness, physical function, and quality of life measures. Disease outcomes were compared based on race and income. RESULTS: Minority subjects were significantly more likely to have low annual family income and significantly worse scores on measures of physical function, disease activity, and quality of life measures. Subjects with lower annual family income had worse scores on measures of physical function, disease activity, and quality of life scores, as well as weakness. Black subjects were more likely to have calcinosis. Despite these differences in outcome measures, there were no significant differences among the racial groups in time to diagnosis or duration of disease. Using calcinosis as a marker of disease morbidity, black race, annual family income <$50 000 per year, negative antinuclear antibody, and delay in diagnosis >12 months were associated with calcinosis. CONCLUSION: Minority race and lower family income are associated with worse morbidity and outcomes in subjects with JDM. Calcinosis was more common in black subjects. Further studies are needed to examine these associations in more detail, to support efforts to address health disparities in subjects with JDM and improve disease outcomes.
Authors: J O Sato; A M E Sallum; V P L Ferriani; R Marini; S B Sacchetti; E M Okuda; J F Carvalho; R M R Pereira; C A Len; M T Terreri; S A Lotufo; P R Romanelli; V C S Ramos; M O Hilario; C A Silva; J E Corrente; C Saad-Magalhães Journal: Clin Exp Rheumatol Date: 2009 Nov-Dec Impact factor: 4.473
Authors: Terrance P O'Hanlon; Lisa G Rider; Adam Schiffenbauer; Ira N Targoff; Karen Malley; Janardan P Pandey; Frederick W Miller Journal: Arthritis Rheum Date: 2008-10
Authors: Angela Byun Robinson; Mark F Hoeltzel; Dawn M Wahezi; Mara L Becker; Elizabeth A Kessler; Heinrike Schmeling; Ruy Carrasco; Adam M Huber; Brian M Feldman; Ann M Reed Journal: Arthritis Care Res (Hoboken) Date: 2014-03 Impact factor: 4.794
Authors: Chester V Oddis; Ann M Reed; Rohit Aggarwal; Lisa G Rider; Dana P Ascherman; Marc C Levesque; Richard J Barohn; Brian M Feldman; Michael O Harris-Love; Diane C Koontz; Noreen Fertig; Stephanie S Kelley; Sherrie L Pryber; Frederick W Miller; Howard E Rockette Journal: Arthritis Rheum Date: 2013-02
Authors: L M Pachman; J R Hayford; A Chung; C A Daugherty; M A Pallansch; C W Fink; H L Gewanter; R Jerath; B A Lang; J Sinacore; I S Szer; A R Dyer; M C Hochberg Journal: J Rheumatol Date: 1998-06 Impact factor: 4.666
Authors: Takayuki Kishi; William Warren-Hicks; Nastaran Bayat; Ira N Targoff; Adam M Huber; Michael M Ward; Lisa G Rider Journal: Rheumatology (Oxford) Date: 2021-05-14 Impact factor: 7.580
Authors: Vladislav Tsaltskan; Annette Aldous; Sam Serafi; Anna Yakovleva; Heidi Sami; Gulnara Mamyrova; Ira N Targoff; Adam Schiffenbauer; Frederick W Miller; Samuel J Simmens; Rodolfo Curiel; Olcay Y Jones; Lisa G Rider Journal: Semin Arthritis Rheum Date: 2019-06-28 Impact factor: 5.532
Authors: Takayuki Kishi; Nastaran Bayat; Michael M Ward; Adam M Huber; Lan Wu; Gulnara Mamyrova; Ira N Targoff; William J Warren-Hicks; Frederick W Miller; Lisa G Rider Journal: Semin Arthritis Rheum Date: 2018-03-28 Impact factor: 5.532
Authors: Francisco Airton Castro Rocha; Joaquim Ivo Vasques Dantas Landim; Marcela Gondim Aguiar; João Pedro Emrich Accioly; Carolina Noronha Lechiu; Luiza Helena Acácio Costa; Carlos Nobre Rabelo Júnior; Leila Nascimento da Rocha; Hermano Alexandre Lima Rocha Journal: Rheumatol Int Date: 2018-08-13 Impact factor: 2.631
Authors: Melody P Chung; Carrie Richardson; David Kirakossian; Amir B Orandi; Lesley A Saketkoo; Lisa G Rider; Adam Schiffenbauer; Carlos A von Mühlen; Lorinda Chung Journal: Autoimmun Rev Date: 2020-03-28 Impact factor: 9.754
Authors: Ruchi N Patel; Valeria G Esparza; Jin-Shei Lai; Elizabeth L Gray; Bryce B Reeve; Rowland W Chang; David Cella; Kaveh Ardalan Journal: Arthritis Care Res (Hoboken) Date: 2021-07-30 Impact factor: 5.178